Biopol Chemicals IPO
GMP, Subscription, Price, Dates & Financial Details
Chemicals
Incorporated in 2023 as Biopol Chemicals Private Limited, the company was subsequently converted into a public limited company and renamed Biopol Chemicals Limited in May 2024, following the acquisition of the proprietorship firm M/s United Chemical Company.Biopol Chemicals Limited is engaged in…
Open Date
Fri, 06 Feb 2026
Close Date
Tue, 10 Feb 2026
Price Band
₹ 102 – 108
Lot Size
1200
Issue Size
₹ 31.00 Cr
Minimum Investment
₹ 259,200 (2400 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Biopol Chemicals IPO has successfully completed its IPO process and is now listed on NSE SME Platform. According to the Red Herring Prospectus (RHP), the IPO was a book-built issue with a total issue size of ₹31.00 Crore, comprising a fresh issue of 28.94 Lakh equity shares aggregating to ₹31.00 Crore.
The Biopol Chemicals IPO remained open for subscription from February 06, 2026, to February 10, 2026. The basis of allotment was finalized on February 11, 2026, and the company's shares were listed on NSE SME Platform on February 13, 2026.
The company had fixed the price band at ₹102 to ₹108 per share, with a lot size of 1200 shares. Retail investors were required to make a minimum investment of ₹259,200 (based on the upper price band) to apply for one lot.
Bigshare Services Pvt Ltd served as the registrar to the issue. Smart Horizon Capital Advisors Private Limited acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Biopol Chemicals Private Limited is now a publicly listed company on NSE SME Platform. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Biopol Chemicals IPO Timeline (Tentative)
- IPO Open Date
- Fri, 06 Feb 26
- IPO Close Date
- Tue, 10 Feb 26
- Basis of Allotment
- Wed, 11 Feb 26
- Initiation of Refunds
- Thu, 12 Feb 26
- Credit of Shares to Demat
- Thu, 12 Feb 26
- Listing Date
- Fri, 13 Feb 26 — NSE & BSE
Open Date
06 February 2026
Close Date
10 February 2026
Basis Of Allotment
11 February 2026
Listing Date
13 February 2026
IPO Subscription
Check Live Subscription →The Biopol Chemicals IPO has received bids for 6,14,16,000 shares against 27,43,200 shares offered, resulting in an overall subscription of 22.39x. the NII category is subscribed 24.62x, Retail Investors 20.8x, and QIBs 21.05x. Within the NII category, BNII is subscribed 27.69x, while SNII is subscribed 18.48x.
QIB
21.05x
NII
24.62x
BNII
27.69x
SNII
18.48x
RII
20.8x
Total
22.39x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 9,62,400 shares, representing 35.08% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 6,86,400 shares (25.02%), while Non-Institutional Investors (NIIs) receive 10,94,400 shares (39.9%).
| Category | Shares Offered | Shares Offered % |
|---|---|---|
| Qualified Institutions | 686,400 | 25.02% |
| Non-Institutional | 1,094,400 | 39.9% |
| BNII | 729,600 | 26.6% |
| SNII | 364,800 | 13.3% |
| Retail Investors | 962,400 | 35.08% |
| Total | 2,743,200 | 100% |
Financials Details(₹ in Crores)
| Particular | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 48.88 | 31.48 | 17.56 |
| Revenue | 48.97 | 49.15 | 17.43 |
| Profit After Tax | 6 | 4.33 | 2.96 |
| Net Worth | 19.54 | 13.53 | 9.2 |
| Reserve & Surplus | 11.63 | 5.62 | 1.29 |
| Total Borrowings | 14.92 | 7.69 | 3.58 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Biopol Chemicals Private Limited KPI Information
| Particular | Dec 2025 | Mar 2025 | Mar 2024 |
|---|---|---|---|
| ROE % | 36.32 | 38.1 | 53.91 |
| ROCE % | 26.32 | 30.57 | 34.03 |
| Debt / Equity | 0.76 | 0.57 | 0.39 |
| RoNW % | 30.74 | 32 | 32.19 |
| Pat Margin % | 12.29 | 8.81 | 11.63 |
Peers Comparison
| Company | Face Value | PE Ratio | EPS Basic | EPS Diluted | RoNW | Net Assets |
|---|---|---|---|---|---|---|
| Biopol Chemicals Ltd | 10 | 0.00 | 5.49 | 5.49 | 32.07 | 17.12 |
| Rossari Biotech Ltd | 2 | 20.93 | 24.63 | 24.63 | 15.62 | 194.56 |
| Fineotex Chemical Ltd | 2 | 2.30 | 9.44 | 9.44 | 19.31 | 54.93 |
| Indian Emulsifiers Ltd | 10 | 7.19 | 10.88 | 10.88 | 20.01 | 91.04 |
About Biopol Chemicals Private Limited
Incorporated in 2023 as Biopol Chemicals Private Limited, the company was subsequently converted into a public limited company and renamed Biopol Chemicals Limited in May 2024, following the acquisition of the proprietorship firm M/s United Chemical Company.
Biopol Chemicals Limited is engaged in the manufacturing and distribution of specialty chemicals, primarily classified under four categories — silicones, emulsifiers, biochemicals, and polyelectrolytes. The company’s product portfolio comprises 66 products, including 40 silicone-based, 5 emulsifier-based, 15 biochemical, and 6 polyelectrolyte products. These products cater to a wide range of industries such as textiles, home care, agriculture, and industrial chemicals.
In addition to its manufacturing operations, Biopol also provides technical consultancy services, offering expertise in textile processing, dye manufacturing, and industrial chemical formulation.
The company operates on a business-to-business (B2B) model, serving institutional clients through a combination of direct sales and a distributor network. Biopol has established a strong domestic presence across West Bengal, Gujarat, Maharashtra, Tamil Nadu, and Karnataka, and also exports its products, primarily to Bangladesh, a key center for the global textile and apparel industry.
Biopol Chemicals IPO Promoters
- Mr. Santanu Sarkar
- Mr. Vedant Sarkar
Promoters Holding
Holding Pre Issue
89.88%
Holding Post Issue
65.81%
Biopol Chemicals IPO Objective
The Company Biopol Chemicals IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Acquisition of industrial land
- Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banking financial companies
- General Corporate Purposes
Biopol Chemicals Private Limited Address / Contact Details
Biopol Chemicals Ltd.
D-211, 2nd Floor, Block-D,
Sumel Business Park-6 Near Dudheshwar Circle
Dudheshwar Tavdipura
Ahmedabad, Gujarat, 380004
Phone: +91- 9147076778
Email: investors@biopolchemicals.com
Website: https://biopolchemicals.com/
IPO Snapshot
Biopol Chemicals IPO Lot Size
The Biopol Chemicals IPO has a lot size of 1,200 shares. Retail investors require a minimum investment of ₹0 by applying for 2 lot (2,59,200 shares). The maximum application allowed for the retail category is 2 lots (2,59,200 shares), requiring an investment of ₹0.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 259,200 | 0.00 |
| Retail (Max) | 2 | 259,200 | 0.00 |
| S-HNI (Min) | 3 | 388,800 | 0.00 |
| S-HNI (Max) | 7 | 907,200 | 0.00 |
| B-HNI (Min) | 8 | 1,036,800 | 0.00 |
Issue Reservation
- QIB — 25.02%
- NII — 39.9%
- RII — 35.08%
Book Running Lead Managers
- Smart Horizon Capital Advisors Private Limited
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Biopol Chemicals IPO?
Biopol Chemicals IPO is a Book-building IPO with a total issue size of ₹31 crore. The Biopol Chemicals IPO price band is ₹102 to 108 per share. The Biopol Chemicals IPO subscription opens on Fri, Feb 6, 2026, and closes on Tue, Feb 10, 2026. The Biopol Chemicals IPO will be listed on the NSE. Bigshare Services Pvt Ltd is the registrar for the Biopol Chemicals IPO.
When will the Biopol Chemicals IPO open for subscription?
The Biopol Chemicals IPO opens on Fri, Feb 6, 2026 and closes on Tue, Feb 10, 2026
What is Biopol Chemicals IPO Price Band?
Biopol Chemicals IPO Price Band is ₹102 to 108 per share.
What is Biopol Chemicals IPO Lot Size?
Biopol Chemicals IPO lot size is 1200 shares, Retail investors need a minimum investment of ₹259200 based on the upper price band
What is the minimum investment for Biopol Chemicals IPO?
The minimum investment for Biopol Chemicals IPO is ₹259200, based on one lot of 1200 shares at the upper price band of ₹108 per share.
How to apply for Biopol Chemicals IPO?
Investors can apply for the Biopol Chemicals IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Tue, Feb 10, 2026. The application amount remains blocked until the Biopol Chemicals IPO allotment is finalized.
What is Biopol Chemicals IPO Issue Size?
Biopol Chemicals IPO issue size is ₹31 crores.
What is the Biopol Chemicals IPO Allotment Date?
Biopol Chemicals IPO allotment date is Wed, Feb 11, 2026.
Who is the Biopol Chemicals IPO Registrar?
The registrar for Biopol Chemicals IPO is Bigshare Services Pvt Ltd. Investors can go to Bigshare Services Pvt Ltd website to check Biopol Chemicals IPO allotment status, refund processing, and other IPO-related information.
What is the Biopol Chemicals IPO GMP?
The Biopol Chemicals IPO GMP (Grey Market Premium) is ₹1 as of Fri, Feb 13, 2026. Based on the upper price band of ₹108 per share, the estimated Biopol Chemicals IPO listing price is ₹109, indicating a potential listing gain of approximately 0.93% over the issue price.
Who is the Biopol Chemicals IPO Lead Manager?
The book-running lead managers (BRLMs) for the Biopol Chemicals IPO are Smart Horizon Capital Advisors Private Limited. The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Biopol Chemicals IPO Red Herring Prospectus (RHP).